Trade Nano-X Imaging Ltd. - NNOX CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
Spread | 0.07 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Prev. Close* | 9.85 |
Open* | 9.91 |
1-Year Change* | 67.4% |
Day's Range* | 9.71 - 10.08 |
52 wk Range | 4.89-22.69 |
Average Volume (10 days) | 605.24K |
Average Volume (3 months) | 15.32M |
Market Cap | 331.96M |
P/E Ratio | -100.00K |
Shares Outstanding | 57.73M |
Revenue | 9.64M |
EPS | -1.91 |
Dividend (Yield %) | N/A |
Beta | 1.82 |
Next Earnings Date | Mar 7, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 28, 2024 | 9.72 | -0.17 | -1.72% | 9.89 | 10.15 | 9.61 |
Mar 27, 2024 | 9.85 | 0.76 | 8.36% | 9.09 | 9.86 | 9.09 |
Mar 26, 2024 | 9.11 | -0.65 | -6.66% | 9.76 | 9.88 | 9.07 |
Mar 25, 2024 | 9.72 | 0.18 | 1.89% | 9.54 | 10.08 | 9.54 |
Mar 22, 2024 | 9.44 | -0.65 | -6.44% | 10.09 | 10.18 | 9.42 |
Mar 21, 2024 | 10.22 | -0.93 | -8.34% | 11.15 | 12.25 | 10.00 |
Mar 20, 2024 | 11.02 | 0.58 | 5.56% | 10.44 | 11.44 | 10.44 |
Mar 19, 2024 | 10.79 | -0.01 | -0.09% | 10.80 | 11.10 | 10.24 |
Mar 18, 2024 | 11.34 | -0.03 | -0.26% | 11.37 | 11.49 | 10.25 |
Mar 15, 2024 | 10.71 | 0.83 | 8.40% | 9.88 | 11.26 | 9.69 |
Mar 14, 2024 | 10.00 | -0.16 | -1.57% | 10.16 | 10.75 | 9.34 |
Mar 13, 2024 | 9.81 | 0.22 | 2.29% | 9.59 | 10.00 | 9.47 |
Mar 12, 2024 | 9.57 | 0.14 | 1.48% | 9.43 | 9.77 | 9.31 |
Mar 11, 2024 | 9.36 | -0.68 | -6.77% | 10.04 | 10.28 | 9.32 |
Mar 8, 2024 | 10.17 | -0.05 | -0.49% | 10.22 | 11.29 | 9.96 |
Mar 7, 2024 | 10.20 | 0.02 | 0.20% | 10.18 | 10.77 | 10.08 |
Mar 6, 2024 | 10.49 | 0.59 | 5.96% | 9.90 | 11.12 | 9.88 |
Mar 5, 2024 | 9.98 | -0.41 | -3.95% | 10.39 | 10.79 | 9.78 |
Mar 4, 2024 | 10.86 | -0.16 | -1.45% | 11.02 | 11.34 | 10.34 |
Mar 1, 2024 | 11.07 | -0.15 | -1.34% | 11.22 | 11.36 | 10.58 |
Nano-X Imaging Ltd. Events
Time (UTC) | Country | Event |
---|---|---|
Monday, April 1, 2024 | ||
Time (UTC) 12:30 | Country US
| Event Q4 2023 Nano-X Imaging Ltd Earnings Call Q4 2023 Nano-X Imaging Ltd Earnings CallForecast -Previous - |
Time (UTC) 12:30 | Country US
| Event Q4 2023 Nano-X Imaging Ltd Earnings Release Q4 2023 Nano-X Imaging Ltd Earnings ReleaseForecast -Previous - |
Monday, May 20, 2024 | ||
Time (UTC) 12:30 | Country US
| Event Q1 2024 Nano-X Imaging Ltd Earnings Release Q1 2024 Nano-X Imaging Ltd Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 8.578 | 1.304 | 0 | 0 | 0 |
Total Operating Expense | 126.288 | 62.862 | 43.923 | 22.571 | 1.904 |
Selling/General/Admin. Expenses, Total | 36.492 | 37.266 | 34.713 | 19.854 | 1.232 |
Research & Development | 26.507 | 17.122 | 9.21 | 2.717 | 0.672 |
Operating Income | -117.71 | -61.558 | -43.923 | -22.571 | -1.904 |
Other, Net | 0.108 | 0.008 | -0.005 | ||
Net Income Before Taxes | -116.921 | -61.846 | -43.815 | -22.563 | -1.909 |
Net Income After Taxes | -113.243 | -61.798 | -43.815 | -22.563 | -1.909 |
Net Income Before Extra. Items | -113.243 | -61.798 | -43.815 | -22.563 | -1.909 |
Net Income | -113.243 | -61.798 | -43.815 | -22.563 | -1.909 |
Income Available to Common Excl. Extra. Items | -113.243 | -61.798 | -43.815 | -22.563 | -1.909 |
Income Available to Common Incl. Extra. Items | -113.243 | -61.798 | -43.815 | -22.563 | -1.909 |
Diluted Net Income | -113.243 | -61.798 | -43.815 | -22.563 | -1.909 |
Diluted Weighted Average Shares | 52.235 | 48.216 | 35.654 | 44.3939 | 44.3939 |
Diluted EPS Excluding Extraordinary Items | -2.16795 | -1.28169 | -1.22889 | -0.50825 | -0.043 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
Diluted Normalized EPS | -1.42338 | -1.22135 | -1.22889 | -0.50825 | -0.043 |
Revenue | 8.578 | 1.304 | |||
Cost of Revenue, Total | 15.458 | 2.816 | |||
Gross Profit | -6.88 | -1.512 | |||
Unusual Expense (Income) | 59.663 | 4.476 | |||
Other Operating Expenses, Total | -12.185 | 1.182 | |||
Interest Income (Expense), Net Non-Operating | 0.789 | -0.288 | |||
Depreciation / Amortization | 0.353 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 2.582 | 2.447 | 2.132 | 2.438 | 2.2 |
Total Operating Expense | 20.413 | 14.525 | 55.888 | 22.267 | 24.383 |
Selling/General/Admin. Expenses, Total | 6.183 | 6.628 | 6.119 | 8.589 | 10.065 |
Research & Development | 6.913 | 6.286 | 7.095 | 6.089 | 6.493 |
Unusual Expense (Income) | 2.181 | 2.236 | 40.1 | 3.595 | 3.773 |
Operating Income | -17.831 | -12.078 | -53.756 | -19.829 | -22.183 |
Other, Net | |||||
Net Income Before Taxes | -17.451 | -11.855 | -53.869 | -19.524 | -21.712 |
Net Income After Taxes | -17.364 | -11.761 | -52.837 | -19.126 | -19.614 |
Net Income Before Extra. Items | -17.364 | -11.761 | -52.837 | -19.126 | -19.614 |
Net Income | -17.364 | -11.761 | -52.837 | -19.126 | -19.614 |
Income Available to Common Excl. Extra. Items | -17.364 | -11.761 | -52.837 | -19.126 | -19.614 |
Income Available to Common Incl. Extra. Items | -17.364 | -11.761 | -52.837 | -19.126 | -19.614 |
Diluted Net Income | -17.364 | -11.761 | -52.837 | -19.126 | -19.614 |
Diluted Weighted Average Shares | 55.375 | 55.157 | 52.4 | 52.276 | 52.192 |
Diluted EPS Excluding Extraordinary Items | -0.31357 | -0.21323 | -1.00834 | -0.36587 | -0.3758 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.28797 | -0.18688 | -0.51092 | -0.32117 | -0.32882 |
Revenue | 2.582 | 2.447 | 2.132 | 2.438 | 2.2 |
Cost of Revenue, Total | 4.273 | 3.97 | 3.879 | 3.897 | 3.955 |
Gross Profit | -1.691 | -1.523 | -1.747 | -1.459 | -1.755 |
Other Operating Expenses, Total | 0.766 | -4.692 | -1.305 | 0 | 0 |
Interest Income (Expense), Net Non-Operating | 0.38 | 0.223 | -0.113 | 0.305 | 0.471 |
Depreciation / Amortization | 0.097 | 0.097 | 0.097 | 0.097 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 82.461 | 94.857 | 219.793 | 9.636 | 1.699 |
Cash and Short Term Investments | 77.624 | 88.711 | 213.468 | 8.072 | 0.005 |
Cash & Equivalents | 38.463 | 66.645 | 213.468 | 8.072 | 0.005 |
Prepaid Expenses | 2.414 | 3.129 | 6.325 | 1.564 | 1.694 |
Total Assets | 253.933 | 363.17 | 236.149 | 11.871 | 1.855 |
Property/Plant/Equipment, Total - Net | 44.702 | 39.16 | 15.379 | 0.754 | 0.156 |
Property/Plant/Equipment, Total - Gross | 46.365 | 40.028 | 15.723 | 0.89 | 0.239 |
Accumulated Depreciation, Total | -1.663 | -0.868 | -0.344 | -0.136 | -0.083 |
Other Long Term Assets, Total | 2.933 | 1.184 | 0.977 | 1.481 | 0 |
Total Current Liabilities | 25.074 | 52.751 | 4.48 | 20.263 | 8.239 |
Accounts Payable | 3.619 | 3.134 | 0.435 | 0.475 | 0.082 |
Accrued Expenses | 12.98 | 4.492 | 4.045 | 1.968 | 0 |
Notes Payable/Short Term Debt | 0 | 0.145 | 0 | 0 | 0 |
Other Current Liabilities, Total | 8.475 | 44.98 | 17.82 | 8.157 | |
Total Liabilities | 37.253 | 71.022 | 5.403 | 20.649 | 8.239 |
Total Long Term Debt | 3.481 | 3.796 | 0 | 0 | 0 |
Other Liabilities, Total | 5.368 | 7.412 | 0.923 | 0.386 | 0 |
Total Equity | 216.68 | 292.148 | 230.746 | -8.778 | -6.384 |
Common Stock | 0.158 | 0.149 | 0.131 | 0.075 | 0.058 |
Additional Paid-In Capital | 477.953 | 438.82 | 315.031 | 31.748 | 11.596 |
Retained Earnings (Accumulated Deficit) | -259.457 | -146.214 | -84.416 | -40.601 | -18.038 |
Total Liabilities & Shareholders’ Equity | 253.933 | 363.17 | 236.149 | 11.871 | 1.855 |
Total Common Shares Outstanding | 55.0942 | 51.7914 | 46.1002 | 44.3939 | 44.3939 |
Short Term Investments | 39.161 | 22.066 | |||
Total Receivables, Net | 0.977 | 1.051 | |||
Accounts Receivable - Trade, Net | 0.977 | 1.051 | |||
Other Current Assets, Total | 1.446 | 1.966 | |||
Goodwill, Net | 7.42 | 58.298 | |||
Intangibles, Net | 91.219 | 101.826 | |||
Long Term Investments | 25.198 | 67.845 | |||
Long Term Debt | 3.481 | 3.796 | |||
Deferred Income Tax | 3.33 | 7.063 | |||
Other Equity, Total | -1.974 | -0.607 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total Current Assets | 77.519 | 81.855 | 82.461 | 90.61 | 89.766 |
Cash and Short Term Investments | 74.464 | 78.091 | 77.624 | 88.037 | 86.634 |
Cash & Equivalents | 41.998 | 37.571 | 38.463 | 40.331 | 51.676 |
Prepaid Expenses | 0.901 | 1.501 | 2.414 | 0.103 | 0.804 |
Total Assets | 224.885 | 238.965 | 253.933 | 305.686 | 317.724 |
Property/Plant/Equipment, Total - Net | 46.453 | 46.588 | 44.702 | 45.367 | 44.456 |
Other Long Term Assets, Total | 1.76 | 1.718 | 2.933 | 2.858 | 2.954 |
Total Current Liabilities | 23.433 | 24.167 | 25.074 | 43.592 | 40.612 |
Accounts Payable | 3.967 | 3.716 | 3.619 | 5.588 | 1.858 |
Accrued Expenses | 13.205 | 12.903 | 12.98 | 2.909 | 3.801 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0.145 | 0.145 |
Total Liabilities | 31.35 | 32.235 | 37.253 | 57.854 | 55.448 |
Total Long Term Debt | 3.428 | 3.451 | 3.481 | 3.481 | 3.481 |
Other Liabilities, Total | 1.347 | 1.381 | 5.368 | 6.443 | 6.588 |
Total Equity | 193.535 | 206.73 | 216.68 | 247.832 | 262.276 |
Common Stock | 0.159 | 0.158 | 0.158 | 0.15 | 0.15 |
Additional Paid-In Capital | 482.971 | 479.172 | 477.953 | 456.761 | 451.825 |
Retained Earnings (Accumulated Deficit) | -288.582 | -271.218 | -259.457 | -206.62 | -187.494 |
Total Liabilities & Shareholders’ Equity | 224.885 | 238.965 | 253.933 | 305.686 | 317.724 |
Total Common Shares Outstanding | 55.5598 | 55.1503 | 55.0942 | 52.2665 | 52.2147 |
Short Term Investments | 32.466 | 40.52 | 39.161 | 47.706 | 34.958 |
Long Term Investments | 5.82 | 12.818 | 25.198 | 29.023 | 40.067 |
Other Equity, Total | -1.013 | -1.382 | -1.974 | -2.459 | -2.205 |
Long Term Debt | 3.428 | 3.451 | 3.481 | 3.481 | 3.481 |
Total Receivables, Net | 1.431 | 1.308 | 0.977 | 1.121 | 1.203 |
Accounts Receivable - Trade, Net | 1.431 | 1.308 | 0.977 | 1.121 | 1.203 |
Other Current Assets, Total | 0.723 | 0.955 | 1.446 | 1.349 | 1.125 |
Goodwill, Net | 7.42 | 7.42 | 7.42 | 43.96 | 43.96 |
Intangibles, Net | 85.913 | 88.566 | 91.219 | 93.868 | 96.521 |
Other Current Liabilities, Total | 6.261 | 7.548 | 8.475 | 34.95 | 34.808 |
Deferred Income Tax | 3.142 | 3.236 | 3.33 | 4.338 | 4.767 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -113.243 | -61.798 | -43.815 | -22.563 | -1.909 |
Cash From Operating Activities | -43.385 | -38.071 | -21.487 | -5.524 | -3.671 |
Cash From Operating Activities | 0.905 | 0.524 | 0.208 | 0.053 | 0.035 |
Non-Cash Items | 71.024 | 18.804 | 24.781 | 16.245 | 0.115 |
Changes in Working Capital | -8.945 | 2.747 | -2.661 | 0.741 | -1.912 |
Cash From Investing Activities | 14.606 | -116.32 | -13.937 | -0.125 | -0.073 |
Capital Expenditures | -7.171 | -23.158 | -13.937 | -0.125 | -0.073 |
Cash From Financing Activities | 0.804 | 7.379 | 240.991 | 13.861 | 3.684 |
Financing Cash Flow Items | -0.145 | 0 | -0.339 | 0 | |
Issuance (Retirement) of Stock, Net | 0.949 | 3.583 | 240.991 | 14.2 | 3.684 |
Net Change in Cash | -28.243 | -147.012 | 205.567 | 8.212 | -0.06 |
Amortization | 10.607 | 1.768 | |||
Deferred Taxes | -3.733 | -0.116 | |||
Other Investing Cash Flow Items, Total | 21.777 | -93.162 | |||
Issuance (Retirement) of Debt, Net | 0 | 3.796 | |||
Cash Taxes Paid | 0.147 | ||||
Cash Interest Paid | 0.09 | ||||
Foreign Exchange Effects | -0.268 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -11.761 | -113.243 | -60.406 | -41.28 | -21.666 |
Cash From Operating Activities | -10.674 | -43.385 | -30.507 | -22.284 | -10.955 |
Cash From Operating Activities | 0.255 | 0.905 | 0.626 | 0.404 | 0.206 |
Amortization | 2.653 | 10.607 | 7.958 | 5.305 | 2.653 |
Deferred Taxes | -0.094 | -3.733 | -2.725 | -2.296 | -0.178 |
Non-Cash Items | 1.671 | 71.024 | 29.927 | 25.415 | 6.946 |
Changes in Working Capital | -3.398 | -8.945 | -5.887 | -9.832 | 1.084 |
Cash From Investing Activities | 9.616 | 14.606 | 3.501 | -6.77 | -1.12 |
Capital Expenditures | -1.495 | -7.171 | -7.387 | -5.76 | -3.815 |
Other Investing Cash Flow Items, Total | 11.111 | 21.777 | 10.888 | -1.01 | 2.695 |
Cash From Financing Activities | 0.176 | 0.804 | 0.63 | 14.082 | 0.387 |
Financing Cash Flow Items | -0.145 | 13.557 | |||
Issuance (Retirement) of Stock, Net | 0.176 | 0.949 | 0.63 | 0.525 | 0.387 |
Issuance (Retirement) of Debt, Net | 0 | 0 | |||
Net Change in Cash | -0.893 | -28.243 | -26.376 | -14.972 | -11.724 |
Cash Taxes Paid | 0 | 0.116 | |||
Cash Interest Paid | 0.04 | 0.017 | |||
Foreign Exchange Effects | -0.011 | -0.268 | -0.036 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Nano-X Imaging Ltd. Company profile
Nano-X Imaging Ltd. (NNOX) is a medical imaging technology company that develops, manufactures and commercialises digital X-ray source technology based on a novel digital micro-electromechanical systems (MEMS) semiconductor cathode.
Founded in 2011 and headquartered in Neve Ilan, Israel, Nano-X Imaging leverages disruptive technology to transform and aid the medical industry.
The company aims to reduce the cost of medical imaging systems. Its imaging products are designed to transmit all imaging data to the cloud Software as a Service (SaaS) platform, which would employ a matching engine to match scans to radiologists.
Nano-X’s proprietary technologies include Nanox.ARC, Nanox.CLOUD and Nanox.TUBE.
Nanox.ARC is a medical imaging system that incorporates the novel digital X-ray source, while the Nanox.CLOUD is a companion cloud-based software that allows the delivery of medical screening as a service.
The Nanox.CART X-Ray System has received United States Food and Drug Administration (FDA) clearance using the Nanox.SOURCE.
The company also provides Nanox.CLOUD Services, which is a medical AI system that would provide first response and decision assistive information.
Nano-X Imaging went public on the NASDAQ under the ticker symbol ‘NNOX’ in August 2020.
Industry: | Medical Imaging Systems |
Communications Center
NEVE 'ILAN
9085000
IL
Income Statement
- Annual
- Quarterly
News
A way forward: a roundup of recent central bank decisions
Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.
12:47, 22 March 2024Bank of Japan Preview: will the BOJ end negative interest rates?
The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.
08:44, 18 March 2024Higher CPI leaves traders unfazed as US equities continue to build momentum
The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.
12:42, 15 March 2024Four reasons why Bitcoin is surging to record highs
Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.
10:18, 14 March 2024China’s National People’s Congress: The markets have again been left wanting more
China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.
08:23, 8 March 2024Central Banks: which one will cut first?
Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut
13:14, 6 March 2024Nvidia (NVDA) confronts high expectations for Q4 results
Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.
12:13, 20 February 2024People also watch
Still looking for a broker you can trust?
Join the 580.000+ traders worldwide that chose to trade with Capital.com